Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Australia
0
South Africa
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Acetate, Megestrol
2. Apo Megestrol
3. Apo-megestrol
4. Apomegestrol
5. Borea
6. Lin Megestrol
7. Lin-megestrol
8. Linmegestrol
9. Maygace
10. Megace
11. Megefren
12. Megestat
13. Megostat
14. Mestrel
15. Nu Megestrol
16. Nu-megestrol
17. Numegestrol
1. 595-33-5
2. Megace
3. Megace Es
4. Niagestin
5. Megestryl Acetate
6. Megeron
7. Megestat
8. Ovaban
9. Ovarid
10. Maygace
11. Pallace
12. Bdh 1298
13. Magestin
14. Sc 10363
15. Nsc-71423
16. Volidan
17. Sc10363
18. 17alpha-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate
19. Megesterol Acetate
20. 17alpha-acetoxy-6-dehydro-6-methylprogesterone
21. 6-dehydro-6-methyl-17alpha-acetoxyprogesterone
22. 6-methyl-6-dehydro-17alpha-acetoxyprogesterone
23. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
24. 17-acetoxy-6-methylpregna-4,6-diene-3,20-dione
25. Sc-10363
26. 17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione
27. Bdh-1298
28. 6-methyl-17alpha-hydroxy-delta(sup 6)-progesterone Acetate
29. Tj2m0fr8es
30. [(8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthren-17-yl] Acetate
31. Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-
32. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate
33. Megestrol 17.alpha.-acetate
34. Mls000028633
35. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate
36. Bdh1298
37. Smr000058691
38. Dsstox_cid_20683
39. Dsstox_rid_79539
40. Dsstox_gsid_40683
41. Megestil
42. 6-methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione
43. Ovaban (veterinary)
44. 6-methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone
45. Megestrolacetate
46. 6-methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione Acetate
47. Megestrol Acetate [usan]
48. (8xi,9xi,10xi,13xi,14xi)-6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate
49. Ccris 372
50. Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, Acetate
51. Megestrol-17-acetate
52. Einecs 209-864-5
53. Unii-tj2m0fr8es
54. Megestin
55. Megestrol Acetole [progestins]
56. Megestrol Acetate [usan:usp]
57. Megestrol Acetole
58. Megestrol-acetate
59. 17-alpha-acetoxy-6-dehydro-6-methylprogesterone
60. 6-dehydro-6-methyl-17-alpha-acetoxyprogesterone
61. 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone
62. Ncgc00016516-01
63. (8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate
64. Cas-595-33-5
65. Megace (tn)
66. 17alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione
67. 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione
68. 6-methyl-17-alpha-hydroxy-delta(sup 6)-progesterone Acetate
69. 6-methyl-6-dehydro-17.alpha.-acetylprogesterone
70. 6-methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone
71. 6-methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione Acetate
72. 17.alpha.-acetoxy-6-dehydro-6-methylprogesterone
73. 6-dehydro-6-methyl-17.alpha.-acetoxyprogesterone
74. 6-methyl-6-dehydro-17.alpha.-acetoxyprogesterone
75. Megestrol Acetate (usp)
76. Opera_id_1511
77. Prestwick0_000956
78. Prestwick1_000956
79. Prestwick2_000956
80. Prestwick3_000956
81. 6-methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione Acetate
82. Schembl745
83. Bspbio_000952
84. Mls000759501
85. Mls001074091
86. Mls001424055
87. Par-100,2
88. Spbio_003101
89. Megestrol Acetate [mi]
90. Bpbio1_001048
91. Chebi:6723
92. Chembl1201139
93. Dtxsid9040683
94. Megestrol Acetate [vandf]
95. Megestrol Acetate [mart.]
96. Bcpp000168
97. Hms1570p14
98. Hms2051i20
99. Hms2090n04
100. Hms2097p14
101. Hms2235d16
102. Hms3714p14
103. Megestrol Acetate [usp-rs]
104. Megestrol Acetate [who-dd]
105. Megestrol Acetate [who-ip]
106. Nia
107. Nsc71423
108. Zinc4097467
109. Tox21_110469
110. Tox21_302360
111. Lmst02030118
112. Mfcd00056470
113. S1304
114. Akos015894927
115. Megestrol Acetate [green Book]
116. Tox21_110469_1
117. Bcp9000904
118. Ccg-100899
119. Cs-2065
120. Db00351
121. Megestrol Acetate [orange Book]
122. Nc00149
123. Megestrol Acetate [ep Monograph]
124. 17-acetoxy-6-methylpregna-4,20-dione
125. Megestrol Acetate [usp Monograph]
126. Ncgc00024196-03
127. Ncgc00024196-05
128. Ncgc00255456-01
129. Ac-24570
130. As-13384
131. Hy-13676
132. 17.alpha.-acetoxy-6-methyl-4,20-dione
133. Ab00490013
134. B1377
135. 17-hydroxy-6-methylpregna-4,20-dione Acetate
136. 17.alpha.-acetoxy-6-methylpregna-4,20-dione
137. C08151
138. D00952
139. D91560
140. Ab00383046-13
141. Ab00383046-14
142. Ab00383046-15
143. Ab00383046_16
144. Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-
145. 595m335
146. A832354
147. Megestrol-17-acetate 1000 Microg/ml In Methanol
148. Sr-01000000258
149. Megestrol-17-acetate 100 Microg/ml In Acetonitrile
150. Pregna-4,20-dione, 17-hydroxy-6-methyl-, Acetate
151. Q-201346
152. Q6808975
153. Sr-01000000258-4
154. Brd-k19507340-001-03-1
155. Medroxyprogesterone Acetate Impurity G [who-ip]
156. Megestrol Acetate, Vetranal(tm), Analytical Standard
157. Megestrol-17-acetate 100 Microg/ml In Methanol/water
158. 17alpha-acetoxy-6-methyl-4,6-pregnadiene-3,20-dione
159. Megestrol Acetate, Analytical Standard, For Drug Analysis
160. Medroxyprogesterone Acetate Impurity G [ep Impurity]
161. Wln: L E5 B666 Ov Ku Mutj A1 E1 Fv1 Fov1 L1
162. 6-methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone Acetate
163. Megestrol Acetate, European Pharmacopoeia (ep) Reference Standard
164. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate [who-ip]
165. Megestrol Acetate, United States Pharmacopeia (usp) Reference Standard
166. Megesgtrol Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
167. Megestrol Acetate For Peak Identification, European Pharmacopoeia (ep) Reference Standard
168. Megestrol Acetate For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 384.5 g/mol |
---|---|
Molecular Formula | C24H32O4 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 384.23005950 g/mol |
Monoisotopic Mass | 384.23005950 g/mol |
Topological Polar Surface Area | 60.4 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 821 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Megace |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | MEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 40mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 6 | |
---|---|
Drug Name | Megace es |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 125mg/ml |
Market Status | Prescription |
Company | Par Pharm |
3 of 6 | |
---|---|
Drug Name | Megestrol acetate |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL... |
Active Ingredient | Megestrol acetate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 125mg/ml; 40mg/ml; 40mg; 20mg |
Market Status | Prescription |
Company | Twi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr |
4 of 6 | |
---|---|
Drug Name | Megace |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | MEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 40mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
5 of 6 | |
---|---|
Drug Name | Megace es |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 125mg/ml |
Market Status | Prescription |
Company | Par Pharm |
6 of 6 | |
---|---|
Drug Name | Megestrol acetate |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL... |
Active Ingredient | Megestrol acetate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 125mg/ml; 40mg/ml; 40mg; 20mg |
Market Status | Prescription |
Company | Twi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr |
For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used for the palliative management of recurrent, inoperable, or metastatic breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.
FDA Label
Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. These effects include induction of secretory changes in the endometrium, increase in basal body temperature, pituitary inhibition, and production of withdrawal bleeding in the presence of estrogen. Mestrogel has slight glucocorticoid activity and very slight mineralocorticoid activity. This drug has no estrogenic, androgenic, or anabolic activity. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Appetite Stimulants
Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS. (See all compounds classified as Appetite Stimulants.)
Absorption
Variable, but well absorbed orally.
Route of Elimination
The major route of drug elimination in humans is urine. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces.
Primarily hepatic. Megestrol metabolites which were identified in urine constituted 5% to 8% of the dose administered. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces. No active metabolites have been identified.
34 hours
The precise mechanism by which megestrol acetate produces effects in anorexia and cachexia is unknown at the present time, but its progestin antitumour activity may involve suppression of luteinizing hormone by inhibition of pituitary function. Studies also suggest that the megestrol's weight gain effect is related to its appetite-stimulant or metabolic effects rather than its glucocorticoid-like effects or the production of edema. It has also been suggested that megestrol may alter metabolic pathyways via interferences with the production or action of mediators such as cachectin, a hormone that inhibits adipocyte lipogenic enzymes.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Megestrol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Megestrol Acetate, including repackagers and relabelers. The FDA regulates Megestrol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Megestrol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Megestrol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Megestrol Acetate supplier is an individual or a company that provides Megestrol Acetate active pharmaceutical ingredient (API) or Megestrol Acetate finished formulations upon request. The Megestrol Acetate suppliers may include Megestrol Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Megestrol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Megestrol Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Megestrol Acetate active pharmaceutical ingredient (API) in detail. Different forms of Megestrol Acetate DMFs exist exist since differing nations have different regulations, such as Megestrol Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Megestrol Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Megestrol Acetate USDMF includes data on Megestrol Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Megestrol Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Megestrol Acetate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Megestrol Acetate Drug Master File in Korea (Megestrol Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Megestrol Acetate. The MFDS reviews the Megestrol Acetate KDMF as part of the drug registration process and uses the information provided in the Megestrol Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Megestrol Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Megestrol Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Megestrol Acetate suppliers with KDMF on PharmaCompass.
A Megestrol Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Megestrol Acetate Certificate of Suitability (COS). The purpose of a Megestrol Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Megestrol Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Megestrol Acetate to their clients by showing that a Megestrol Acetate CEP has been issued for it. The manufacturer submits a Megestrol Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Megestrol Acetate CEP holder for the record. Additionally, the data presented in the Megestrol Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Megestrol Acetate DMF.
A Megestrol Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Megestrol Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Megestrol Acetate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Megestrol Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Megestrol Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Megestrol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Megestrol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Megestrol Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Megestrol Acetate suppliers with NDC on PharmaCompass.
Megestrol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Megestrol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Megestrol Acetate GMP manufacturer or Megestrol Acetate GMP API supplier for your needs.
A Megestrol Acetate CoA (Certificate of Analysis) is a formal document that attests to Megestrol Acetate's compliance with Megestrol Acetate specifications and serves as a tool for batch-level quality control.
Megestrol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Megestrol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Megestrol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Megestrol Acetate EP), Megestrol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Megestrol Acetate USP).
LOOKING FOR A SUPPLIER?